Revvity Signals Software's New Synergy Solution Redefines Collaboration Between Pharma and Contract PartnersBusiness Wire • 04/15/24
Preliminary Injunction Granted to Enforce Revvity's Rights and Cloud Software Group's Obligations Related to Spotfire SoftwareBusiness Wire • 04/02/24
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software GroupBusiness Wire • 03/20/24
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry CommunicationBusiness Wire • 03/18/24
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven DecisionsBusiness Wire • 02/12/24
Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024Business Wire • 02/02/24
Compared to Estimates, Revvity (RVTY) Q4 Earnings: A Look at Key MetricsZacks Investment Research • 02/01/24
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023Business Wire • 02/01/24
Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of DirectorsBusiness Wire • 01/25/24
Revvity, Inc. (RVTY) CEO Prahlad Singh presents at 42nd Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/09/24
Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial PerformanceBusiness Wire • 01/09/24
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCIDBusiness Wire • 11/27/23